Medical research is advancing treatments for occlusive conditions—blockages in blood vessels and organs—across multiple disease areas including sickle cell disease, cardiovascular events, and rare vascular disorders. Recent developments span new drug trials, AI diagnostic improvements, and clinical settlements related to occlusion-related crises.
·Crovalimab shows promise in controlling vaso-occlusive episodes in sickle cell disease patients
·Etavopivat reduces vaso-occlusive crisis events and improves hemoglobin levels in Phase 3 trials
·AI-based ECG interpretation outperforms standard methods for diagnosing occlusive heart attacks
·Pfizer settles lawsuit over recalled Oxbryta drug linked to vaso-occlusive crises in children
·New surgical technique combines balloon occlusion with thrombectomy and device implantation for atrial appendage
drawn from Docwire News, Neurology® Journals, Nature, AboutLawsuits.com · updated 9d ago